Treatment of Focal Ventricular Tachycardias Using a Pulsed Field Ablation From a Point Ablation Catheter Short Title FOCUS-PFA

Part of paid clinical trials in New York, New York.

Sponsor
Vivek Reddy
Study ID
NCT06747013
Status
Enrolling By Invitation

Conditions

  • Focal Ventricular Arrhythmias
  • Premature Ventricular Contractions
  • Ventricular Tachycardias

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Point Ablation Catheter — DEVICE
    a point ablation catheter using a pulse field energy

Study Details

The purpose of this study is to examine the use of a point ablation catheter (Farapoint, Boston Scientific) in the mapping and ablation of focal ventricular arrhythmias (premature ventricular contractions or ventricular tachycardia) using pulsed field energy.

Key Dates

Start date
Jan 7, 2025
Status verified
Feb 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Ablation using study catheter
    All patients will undergo a standard ablation protocol using the study catheter (Farapoint)

Primary Outcome Measure

Freedom from PVC/VT recurrence [ Time Frame: at 3 months following ablation procedure ]

Locations (1)

FacilityCityStateZIPSite coordinators
Icahn School of Medicine at Mount SinaiNew YorkNew York10029-

Find similar trials in New York, NY

By research site
Icahn School of Medicine at Mount Sinai· New York, NY

Related Studies